Eric Quéméneur
Chief Tech/Sci/R&D Officer bei TRANSGENE
Aktive Positionen von Eric Quéméneur
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| TRANSGENE | Chief Tech/Sci/R&D Officer | 01.09.2014 | - |
| ELSALYS BIOTECH | Director/Board Member | - | - |
| Chief Tech/Sci/R&D Officer | - | - |
Karriereverlauf von Eric Quéméneur
Ehemalige bekannte Positionen von Eric Quéméneur
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| Comité de l’énergie Atomique | Corporate Officer/Principal | 01.09.2010 | 01.09.2014 |
Ausbildung von Eric Quéméneur
| Université Claude Bernard Lyon 1 | Doctorate Degree |
| Institut National des Sciences Appliquées de Lyon | Undergraduate Degree |
Statistik
International
| Frankreich | 6 |
Operativ
| Chief Tech/Sci/R&D Officer | 2 |
| Doctorate Degree | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 3 |
| Government | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| TRANSGENE | Health Technology |
| Private Unternehmen | 2 |
|---|---|
| Comité de l’énergie Atomique | Government |
ElsaLys Biotech SAS
 ElsaLys Biotech SAS Pharmaceuticals: MajorHealth Technology ElsaLys Biotech SAS provides therapeutic monoclonal antibody player services. It involves in cellular events at the core of the pathological process: immune response, angiogenesis, survival, proliferation, adhesion and migration. The company also designs and develops a new generation of antibodies that target tumors and their immune microenvironment. ElsaLys Biotech was founded by Christine Guillen, Thierry Menguy, Vanessa Duong, and Martine Brandt in 2013 and is headquartered in Lyon, France. | Health Technology |
- Börse
- Insiders
- Eric Quéméneur
- Erfahrung
